Search research articles
Contact Us
Filters
Showing results (181-190 of 377) with videos related to
Page
of 38
Sort By:
Cancer
|
August 4, 2005
Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree
Alain Gelibter, Paola Malaguti, Serena Di Cosimo, et al.
Annals of Translational Medicine
|
November 26, 2015
Melanoma: oncogenic drivers and the immune system
Niki Karachaliou, Sara Pilotto, Cristina Teixidó, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2025
Complete Response to Lorlatinib in Lung Adenocarcinoma With EML4-ALK Fusion Variant (E6;A18): Case Report and Literature Review
Antonio Vitale, Elisa De Paolis, Jacopo Russo, et al.
Minerva Surgery
|
August 2, 2021
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis
Armando Orlandi, Sabatino D'Archi, Giovanna Garufi, et al.
Cancer
|
August 10, 2005
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials
Paolo Carlini, Emilio Bria, Diana Giannarelli, et al.
Cancers
|
July 2, 2021
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features
Antonio Passaro, Silvia Novello, Diana Giannarelli, et al.
Oncology Reviews
|
March 30, 2026
How recreational therapies impact physiological and psychosocial outcomes in cancer patients: a review
Marika D'Oria, Calogero Casà, Cristina Cenci, et al.
Critical Reviews in Oncology/Hematology
|
August 12, 2018
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer
Ilaria Trestini, Luisa Carbognin, Sara Monteverdi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 17, 2011
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials
Federica Cuppone, Emilio Bria, Vanja Vaccaro, et al.
Future Oncology (London, England)
|
December 20, 2014
BMI variation increases recurrence risk in women with early-stage breast cancer
Palma Fedele, Laura Orlando, Paola Schiavone, et al.
Page
of 38
Search research articles
Search
Showing results (181-190 of 377) with videos related to
Sort By:
Page
of 38
Cancer
|
August 4, 2005
Fixed dose-rate gemcitabine infusion as first-line treatment for advanced-stage carcinoma of the pancreas and biliary tree
Alain Gelibter, Paola Malaguti, Serena Di Cosimo, et al.
Annals of Translational Medicine
|
November 26, 2015
Melanoma: oncogenic drivers and the immune system
Niki Karachaliou, Sara Pilotto, Cristina Teixidó, et al.
Journal of the National Comprehensive Cancer Network : JNCCN
|
October 8, 2025
Complete Response to Lorlatinib in Lung Adenocarcinoma With EML4-ALK Fusion Variant (E6;A18): Case Report and Literature Review
Antonio Vitale, Elisa De Paolis, Jacopo Russo, et al.
Minerva Surgery
|
August 2, 2021
Impact on survival of primary tumor resection in patients with metastatic breast cancer: preliminary results of a retrospective analysis
Armando Orlandi, Sabatino D'Archi, Giovanna Garufi, et al.
Cancer
|
August 10, 2005
New aromatase inhibitors as second-line endocrine therapy in postmenopausal patients with metastatic breast carcinoma: a pooled analysis of the randomized trials
Paolo Carlini, Emilio Bria, Diana Giannarelli, et al.
Cancers
|
July 2, 2021
Early Progression in Non-Small Cell Lung Cancer (NSCLC) with High PD-L1 Treated with Pembrolizumab in First-Line Setting: A Prognostic Scoring System Based on Clinical Features
Antonio Passaro, Silvia Novello, Diana Giannarelli, et al.
Oncology Reviews
|
March 30, 2026
How recreational therapies impact physiological and psychosocial outcomes in cancer patients: a review
Marika D'Oria, Calogero Casà, Cristina Cenci, et al.
Critical Reviews in Oncology/Hematology
|
August 12, 2018
Clinical implication of changes in body composition and weight in patients with early-stage and metastatic breast cancer
Ilaria Trestini, Luisa Carbognin, Sara Monteverdi, et al.
Journal of Experimental & Clinical Cancer Research : CR
|
May 17, 2011
Magnitude of risks and benefits of the addition of bevacizumab to chemotherapy for advanced breast cancer patients: Meta-regression analysis of randomized trials
Federica Cuppone, Emilio Bria, Vanja Vaccaro, et al.
Future Oncology (London, England)
|
December 20, 2014
BMI variation increases recurrence risk in women with early-stage breast cancer
Palma Fedele, Laura Orlando, Paola Schiavone, et al.
Page
of 38